Robert Anderson

Company: Novoviah Pharmaceuticals

Job title: Co-Founder & Director

Seminars:

Renaissance of Interleukin-2 as a Sensitive Biomarker for Antigen-Driven Clinical Reactions & Monitoring Rare Antigen-Specific T cells in Blood 11:45 am

IL-2 shows as the most dynamic/consistent marker of CD4+ T cell activation in whole blood stimulated with gluten peptides Administration of immunogenic gluten peptides or gluten causes acute symptoms in celiac disease within 2 hours, correlated in timing and magnitude with IL-2 elevations in plasma  Whole blood IL-2 release assays for antigen-specific T cells are…Read more

day: Conference Day One